What is the relationship between axillary cysts and patients with PCOS (Polycystic Ovary Syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no established relationship between axillary cysts and patients with PCOS (Polycystic Ovary Syndrome).

Key Points

  • The provided evidence does not mention axillary cysts in relation to PCOS, focusing instead on the diagnosis, management, and symptoms of PCOS, such as hyperandrogenism, ovulatory dysfunction, and polycystic ovary morphology 1.
  • PCOS is a complex endocrine disorder affecting women of reproductive age, with symptoms including biochemical, clinical, and morphological indicators of androgen excess and ovulatory dysfunction 1.
  • The diagnosis of PCOS is based on the presence of two of three criteria: oligo/anovulation, polycystic ovaries, and clinical or biochemical hyperandrogenism 1.
  • Hyperandrogenism is a key feature of PCOS, present in 75% of cases, and can be diagnosed clinically or biochemically through the measurement of androgen concentrations 1.
  • The evidence highlights the importance of accurate diagnosis and management of PCOS, including lifestyle modifications, pharmacotherapies, and potential surgical interventions, but does not address axillary cysts 1.

From the Research

Relationship Between Axillary Cysts and PCOS

There is limited research directly addressing the relationship between axillary cysts and patients with Polycystic Ovary Syndrome (PCOS). However, some studies provide insight into the broader context of PCOS and its associated conditions:

  • PCOS is a hormonal disorder that affects women of reproductive age, characterized by ovulatory dysfunction, hyperandrogenism, and other metabolic complications 2, 3, 4, 5.
  • The disorder is associated with various health risks, including diabetes, dyslipidemia, fatty liver, and cardiovascular events 3, 4, 5.
  • Research on PCOS has focused on its relationship with benign breast disease (BBD), but no clear association has been found 2.
  • Studies have explored the role of adipose tissue in PCOS, including white adipose tissue (WAT) and brown adipose tissue (BAT), and their implications for metabolic homeostasis 3.
  • Mitochondrial dysfunction has also been investigated as a potential factor in PCOS, with findings suggesting a link between mitochondrial abnormalities and the progression of PCOS 4.
  • The clinical presentation and diagnosis of PCOS involve a range of symptoms, including anovulatory menstrual cycles, infertility, hirsutism, and obesity, as well as ultrasound findings of abnormal ovarian size and morphology 5, 6.

Axillary Cysts and PCOS

  • There is no direct evidence in the provided studies to suggest a specific relationship between axillary cysts and PCOS.
  • However, the studies do highlight the complexity of PCOS and its associated metabolic and hormonal abnormalities, which may have implications for various bodily systems, including the skin and soft tissues 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polycystic Ovary Syndrome and Fibrocystic Breast Disease: An Updated Review.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2021

Research

Polycystic ovary syndrome and adipose tissue.

Annales d'endocrinologie, 2023

Research

Polycystic ovary syndrome and mitochondrial dysfunction.

Reproductive biology and endocrinology : RB&E, 2019

Research

Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome.

Clinical obstetrics and gynecology, 2021

Research

The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Journal of pediatric and adolescent gynecology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.